"Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel"
Sci Rep. 2022 Sep 19;12(1):15663. doi: 10.1038/s41598-022-19621-7. PMID: 36123435
The paper can be accessed here: https://pubmed.ncbi.nlm.nih.gov/36123435/
Share this story